Low-gradient aortic stenosis: impact of prosthesis-patient mismatch on survival

Jean-Luc Monin1, Mehran Monchi, Matthias E W Kirsch

  • 1Department of Cardiology, Assistance Publique-Hôpitaux de Paris, Henri Mondor Hospital, 51 avenue De Lattre de Tassigny, 94010 Créteil, France. jean-luc.monin@hmn.aphp.fr

European Heart Journal
|September 29, 2007
PubMed
Abstract

Insights

Prosthesis-patient mismatch (PPM) did not significantly impact post-operative mortality in patients undergoing surgery for low-gradient aortic stenosis. Complex interventions to avoid moderate PPM may not be justified due to higher risks outweighing benefits.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Aortic Stenosis Management

Background:

  • Low-gradient aortic stenosis (AS) presents unique challenges in surgical management.
  • Prosthesis-patient mismatch (PPM) is a potential concern after aortic valve replacement.
  • The prognostic significance of PPM in low-gradient AS remains debated.

Purpose of the Study:

  • To evaluate the impact of prosthesis-patient mismatch (PPM) on outcomes in patients with low-gradient aortic stenosis (AS).
  • To identify independent predictors of mortality following surgical intervention for low-gradient AS.

Main Methods:

  • A prospective, multicenter study involving 152 consecutive patients with low-gradient AS.
  • Assessment of prosthesis-patient mismatch (PPM) defined by indexed effective orifice area (EOA).
  • Statistical analysis to determine predictors of overall mortality.

Main Results:

  • PPM was present in 57% of patients but did not significantly affect post-operative mortality.
  • Independent predictors of mortality included LV contractile reserve, coronary artery bypass grafting, baseline mean transaortic pressure gradient, prior cancer, and logistic EuroSCORE.
  • Moderate PPM was common and did not correlate with worse survival.

Conclusions:

  • Prosthesis-patient mismatch (PPM) does not appear to influence post-operative mortality in patients with low-gradient aortic stenosis.
  • The pursuit of interventions to avoid moderate PPM in this patient group may not be clinically justified.
  • Surgical decisions should prioritize established mortality predictors over avoiding moderate PPM in low-gradient AS.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
422